Biophysical Analysis of Bacterial CTP Synthase Filaments Formed in the Presence of the Chemotherapeutic Metabolite Gemcitabine-5′-triphosphate
-
Add time:08/26/2019 Source:sciencedirect.com
While enzyme activity is often regulated by a combination of substrate/effector availability and quaternary structure, many cytosolic enzymes may be further regulated through oligomerization into filaments. Cytidine-5′-triphosphate (CTP) synthase (CTPS) forms such filaments—a process that is promoted by the product CTP. The CTP analog and active chemotherapeutic metabolite gemcitabine-5′-triphosphate (dF-dCTP) is a potent inhibitor of CTPS; however, its effect on the enzyme's ability to form filaments is unknown. Alongside electron microscopy studies, dynamic light scattering showed that dF-dCTP induces Escherichia coli CTPS (EcCTPS) to form filaments in solution with lengths ≥ 30 nm in the presence of CTP or dF-dCTP. The substrate UTP blocks formation of filaments and effects their disassembly. EcCTPS variants were constructed to investigate the role of CTP-binding determinants in CTP- and dF-dCTP-dependent filament formation. Substitution of Glu 149 (i.e., E149D), which interacts with the ribose of CTP, caused reduced affinity for both CTP and dF-dCTP, and obviated filament formation. Phe 227 appears to interact with CTP through an edge-on interaction with the cytosine ring, yet the F227A and F227L variants bound CTP and dF-dCTP. F227A EcCTPS did not form filaments, while F227L EcCTPS formed shorter filaments in the presence of CTP or dF-dCTP. Hence, Phe 227 plays a role in filament formation, although replacement by a bulky hydrophobic amino acid is sufficient for limited filament formation. That dF-dCTP can induce filament formation highlights the fact that nucleotide analogs employed as chemotherapeutic agents may affect the filamentous states of enzymes and potentially alter their regulation in vivo.
We also recommend Trading Suppliers and Manufacturers of 3'(O)-(1-oxyl-2,2,5,5-tetramethyl-3-carbonyl pyrrolidine)-8-azidoadenosine 5'-triphosphate (cas 113814-58-7). Pls Click Website Link as below: cas 113814-58-7 suppliers
Prev:Automated parallel synthesis of 5′-triphosphate oligonucleotides and preparation of chemically modified 5′-triphosphate small interfering RNA
Next:Terbium ion-coordinated carbon dots for fluorescent aptasensing of adenosine 5′-triphosphate with unmodified gold nanoparticles) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Solid-phase synthesis of 5′-triphosphate 2′-5′-oligoadenylates analogs with 3′-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs08/29/2019
- Fabrication of adenosine 5′-triphosphate-capped silver nanoparticles: Enhanced cytotoxicity efficacy and targeting effect against tumor cells08/28/2019
- Terbium ion-coordinated carbon dots for fluorescent aptasensing of adenosine 5′-triphosphate with unmodified gold nanoparticles08/27/2019
- Automated parallel synthesis of 5′-triphosphate oligonucleotides and preparation of chemically modified 5′-triphosphate small interfering RNA08/25/2019
- Carborane-linked 2′-deoxyuridine 5′-O-triphosphate as building block for polymerase synthesis of carborane-modified DNA08/24/2019
- Fluorous-assisted synthesis of (E)-5-[3-Aminoallyl]-uridine-5′-triphosphate08/23/2019
- The first chemical synthesis of pyrazofurin 5′-triphosphate08/22/2019


